Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Codex DNA, Inc.
  6. Company
    DNAY   US1920031010

CODEX DNA, INC.

(DNAY)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Codex DNA, Inc. is a synthetic biology company. The Company is focused on enabling researchers to build or write synthetic deoxyribonucleic acid (DNA) and messenger ribonucleic acid (mRNA) that is ready to use in downstream synthetic biology enabled markets. Its synthetic biology solutions include the BioXp 3250 system, BioXp kits, BioXp portal, Benchtop reagent kits and Biofoundry services. Its BioXp system is an end-to-end automated workstation. The Company's BioXp kits contain all the necessary building blocks and reagents, including the Company's Gibson Assembly branded reagents. The BioXp portal is a user-friendly online portal that offers a guided workflow and design tools. Benchtop reagent kits contain all the reagents necessary to proceed with a specific synthetic biology workflow on the benchtop using products generated on the BioXp system. Its Biofoundry services enables a customer to order and receive any of the BioXp system endpoint-ready products.
Sales per Business
20192020Delta
Genomic Tools3.5674%5.1378% +44.33%
Royalties1.2526%1.4522% +15.6%
USD in Million
Sales per region
20192020Delta
United States4.81100%6.58100% +36.86%
USD in Million
Managers
Name Title Age Since
Todd R. Nelson, Dr. President, Chief Executive Officer & Director - 2018
Jennifer Isacoff McNealey Chief Financial Officer 47 -
Daniel G. Gibson Chief Technology Officer 43 2011
Justin O. Emory Vice President-Information Technology 41 2021
Franklin R. Witney, Dr. Independent Director 66 2020
William F. Snider Independent Director 50 2019
Christine A. Tsingos Independent Director 62 2021
Jami K. Dover Nachtsheim Independent Director 61 2021
Andrea Jackson Independent Director - 2021
Thomas H. Braden Vice President-Global Operations 63 2018
Members of the board
Name Title Age Since
Todd R. Nelson, Dr. President, Chief Executive Officer & Director - 2018
Franklin R. Witney, Dr. Independent Director 66 2020
William F. Snider Independent Director 50 2019
Christine A. Tsingos Independent Director 62 2021
Jami K. Dover Nachtsheim Independent Director 61 2021
Andrea Jackson Independent Director - 2021
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 29,291,743 13,860,562 47.3% 0 0.0% 47.3%
Shareholders
NameEquities%
Northpond Ventures LLC 9,844,130 33.6%
Gattaca Mining LLC 6,000,000 20.5%
BroadOak Capital Partners LLC 2,319,045 7.92%
Danaher Corporation 2,294,157 7.83%
Millennium Management LLC 714,870 2.44%
TimesSquare Capital Management LLC 646,700 2.21%
ArrowMark Colorado Holdings LLC 590,269 2.02%
Franklin Advisers, Inc. 538,600 1.84%
Sectoral Asset Management, Inc. 516,306 1.76%
Woodline Partners LP 493,899 1.69%
Company contact information
Codex DNA, Inc.
9535 Waples Street
Suite 100
San Diego, CA 92121-2993

Phone : +1.858.228.4115
Web : http://www.codexdna.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Codex DNA, Inc.
Sector Other Advanced Medical Equipment & Technology